drugset / Trial / NCT02182713
Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study was to evaluate whether 2 puffs of fixed combination of aerosolized 120 mcg salbutamol sulphate (equivalent to 100 mcg of the base) + 20 mcg ipratropium bromide confers significant additional protection against metacholine induced bronchoconstriction in asthmatic atopic patients when compared to 2 puffs of aerosolized 100 mcg salbutamol alone.
Timeline
- Start
- 1998-05
- Primary completion
- 1998-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ipratropium | Small molecule | 20 ug | — |
| Subject | Salbutamol | Unknown | 100 ug | Inhaled |
| Subject | Salbutamol | Unknown | 120 ug | Inhaled |